Stand up for the facts!

Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.

More Info

I would like to contribute

Rush Limbaugh

stated on December 15, 2020 in a radio show segment:

The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19.

A bottle of hydroxychloroquine tablets in Texas City, Texas, on April 7, 2020. (AP/Phillip)

By Bill McCarthy December 16, 2020

No, the AMA didn’t rescind statement on hydroxychloroquine

If Your Time is short

The American Medical Association never took back its March statement concerning hydroxychloroquine. The group tweeted that Rush Limbaugh’s claim is wrong.
The AMA considered a resolution to rescind a previous statement on the drug when the group’s policymaking body met in November. But it ultimately rejected the resolution.
The website Limbaugh cited has corrected its story.

See the sources for this fact-check

Conservative radio host Rush Limbaugh falsely claimed that the American Medical Association rescinded a previous statement and came out in support of hydroxychloroquine, the drug pushed by President Donald Trump for months as a potential treatment for COVID-19.

"Now all of a sudden the AMA (said) — although very quietly — that hydroxychloroquine is okay," Limbaugh said Dec. 15, telling his millions of listeners that the group’s past statements were meant to hurt Trump. "It’s perfectly fine. Go ahead and use it if you want. It can be helpful."

Limbaugh read from an article in the Published Reporter, a website based in South Florida. The website wrote that the AMA "rescinded" a statement related to hydroxychloroquine.

Limbaugh accused the AMA of "knowingly lying about hydroxychloroquine." But as the Poynter Institute reported, the AMA never retracted its statement on the drug. The Published Reporter and other websites that spread similar claims have walked back their reports, and the AMA addressed the matter on Twitter.

"In March, AMA urged caution about prescribing hydroxychloroquine off-label to treat #COVID19," the AMA wrote, with a link to Poynter’s Covering COVID-19 newsletter by Al Tompkins. "Our position remains unchanged. Evidence-based #science & practice must guide these determinations."

In March, AMA urged caution about prescribing hydroxychloroquine off-label to treat #COVID19. Our position remains unchanged. Evidence-based #science & practice must guide these determinations. Thank you @Poynter for the #FactCheck to set record straight https://t.co/hz1j1Xz2St pic.twitter.com/2qfUdFqdRk
— AMA (@AmerMedicalAssn) December 16, 2020

Several inaccurate social media posts from Limbaugh and others accounts were flagged as part of Facebook’s efforts to combat false news and misinformation on its News Feed. (Read more about our partnership with Facebook.) Some were shared by prominent figures, such as actress Kirstie Alley, who tweeted a since-corrected story calling the AMA "soulless hacks."

Instagram posts

stated on November 7, 2024 in Instagram posts

“2,038 suicides have been reported (Nov. 6) following Donald Trump’s election win.”

Limbaugh did not respond to a request for comment.

The AMA’s March 25 statement, issued jointly with pharmacists’ groups and updated in April, signaled opposition to doctors prescribing hydroxychloroquine as a coronavirus treatment or preventative measure, and to facilities ordering the drug in excessive amounts.

The statement cautioned that "no medication has been FDA-approved for use in COVID-19 patients" and warned of supply-chain disruptions for patients who rely on hydroxychloroquine for other chronic conditions, such as rheumatoid arthritis and lupus.

The statement also said "novel off-label use of FDA-approved medications is a matter for the physician’s or other prescriber’s professional judgment." It encouraged "patient-centered care decisions" but said "evidence-based science and practice must guide these determinations."

The U.S. Food and Drug Administration in June revoked its emergency use authorization for use of hydroxychloroquine as a COVID-19 therapy. The agency later cautioned against the drug’s use for the virus outside of the hospital setting after a review of safety issues. There is little sign that hydroxychloroquine is effective for coronavirus patients.

A resolution submitted ahead of a November meeting of the AMA’s policymaking body proposed that the group retract the March statement. The resolution called for an updated statement "notifying patients that further studies are ongoing" and supporting physicians’ use of judgment to prescribe the drug off-label to patients with early COVID-19 symptoms.

The resolution was not adopted, however. The vote against the measure followed "fierce opposition," MedPage Today reported.

The Published Reporter has amended the story Limbaugh cited with a correction in bolded font that said the resolution "was not accepted." Lead Stories also debunked the false claims.

We rate Limbaugh’s claim False.